跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
Ting Yung Chang
, Jo Nan Liao
, Tze Fan Chao
*
, Jennifer Jeanne Vicera
, Chin Yu Lin
, Ta Chuan Tuan
,
Yenn Jiang Lin
,
Shih Lin Chang
,
Li Wei Lo
,
Yu Feng Hu
, Fa Po Chung
, Shih Ann Chen
*
此作品的通信作者
醫學系內科學科
生物藥學研究所
研究成果
:
Review article
›
同行評審
36
引文 斯高帕斯（Scopus）
總覽
指紋
指紋
深入研究「Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Atrial Fibrillation
100%
Oral Anticoagulants
100%
Stroke Prevention in Atrial Fibrillation
100%
Anticoagulant Use
100%
Stroke Prevention
50%
Patient Characteristics
25%
Dementia
25%
Myocardial Infarction
25%
Arrhythmia
25%
Low Dose Rate
25%
Increasing Prevalence
25%
Sudden Cardiac Death
25%
Ischemic Stroke
25%
Warfarin
25%
Non-vitamin K Antagonist Oral Anticoagulants
25%
Major Bleeding
25%
Risk of Ischemic Stroke
25%
Vitamin K Antagonists
25%
Dabigatran
25%
Apixaban
25%
Edoxaban
25%
Rivaroxaban
25%
Medicine and Dentistry
Apoplexy
100%
Atrial Fibrillation
100%
Antithrombotic
100%
Brain Ischemia
40%
Vitamin K Antagonist
40%
Prevalence
20%
Myocardial Infarction
20%
Cardiac Dysrhythmia
20%
Sudden Cardiac Death
20%
Prothrombin
20%
Patient Characteristics
20%
Congestive Heart Failure
20%
Warfarin
20%
Major Bleeding
20%
Dabigatran
20%
Edoxaban
20%
Apixaban
20%
Rivaroxaban
20%
Factor VII
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cerebrovascular Accident
100%
Anticoagulant Agent
100%
Atrial Fibrillation
100%
Brain Ischemia
40%
Antivitamin K
40%
Prevalence
20%
Heart Arrhythmia
20%
Heart Infarction
20%
Congestive Heart Failure
20%
Sudden Cardiac Death
20%
Bleeding
20%
Prothrombin
20%
Blood Clotting Factor 10
20%
Warfarin
20%
Rivaroxaban
20%
Dabigatran
20%
Apixaban
20%
Edoxaban
20%